Late Phase II Confirmatory Study of DE-089 Ophthalmic Solution in Patients With Dry Eye
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Dose response related to efficacy and safety of DE-089 ophthalmic solution are examined in
patients with dry eye, using a multicenter, randomized, double-blind, parallel group
comparison study, and the optimal concentration is determined.